Belite Bio (BLTE) Operating Leases (2022 - 2025)

Belite Bio's Operating Leases history runs 4 years deep, the most recent figure standing at $188000.0 for Q4 2025.

• In Q4 2025, Operating Leases fell 27.97% year-over-year to $188000.0; the TTM figure through Dec 2025 stood at $188000.0 (down 27.97% YoY), while the FY2025 annual figure was $188000.0, down 27.97% from the prior year.
• Operating Leases was $188000.0 for Q4 2025 at Belite Bio, down from $245000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $668000.0 in Q4 2022 to a low of $188000.0 in Q4 2025.
• Historically, Operating Leases has averaged $388000.0 across 4 years, with a median of $261000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Leases dropped 13.47% in 2023, then plunged 54.84% in 2024.
• A 4-year view of Operating Leases shows it stood at $668000.0 in 2022, then decreased by 13.47% to $578000.0 in 2023, then slumped by 54.84% to $261000.0 in 2024, then retreated by 27.97% to $188000.0 in 2025.
• The last three Operating Leases figures came in at $188000.0 (Q4 2025), $245000.0 (Q3 2025), and $261000.0 (Q4 2024), per Business Quant data.